Skip to main content

POTENCIAL TERAPEUTICO DE LA SUPLEMENTACION CON NICOTINAMIDA SOBRE LA ADIPOSIDAD, SEÑALIZACION DE LA INSULINA Y DE LA ENFERMEDAD HIGADO GRASO NO ALCOHÓLICO

PI21/00770

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO
Execution centre IIB-SANT PAU. INSTITUTO DE INVESTIGACION HOSPITAL SANTA CRUZ Y SAN PABLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population, The ILERVAS Prospective Cohort Study

  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Castro, Eva
  • Farràs-Sallés, Cristina|||0000-0001-5956-4116
  • Torres, Gerard|||0000-0002-1417-7320
  • Pamplona, Reinald|||0000-0003-4337-6107
  • Lecube, Albert|||0000-0001-9684-0183
  • Valdivieso, José Manuel
  • Fernández, Elvira|||0000-0001-5236-1762
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Antentas Peraile, María|||0009-0005-8140-203X
  • Barranco-Altirriba, Maria|||0000-0002-1525-210X
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Mauricio, Didac|||0000-0002-2868-0250
Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented. Objective: We aimed to investigate how adherence to a healthy lifestyle, defined as MDiet adherence and PA level, influences SAD progression in subjects from the ILERVAS cohort follow-up. Methods: A study on 3097 participants from the ILERVAS prospective cohort was conducted. MDiet adherence was assessed using the MEDAS score, and PA categories were established using the IPAQ, both categorized into low, moderate, and high levels. Two different lifestyle scores integrating the MDiet and PA categories were built. The presence of atherosclerotic plaques was assessed by carotid and femoral ultrasound examination. Demographic, clinical, and biochemical data were also obtained. Multivariable linear, logistic, and Poisson regression models adjusted for potential confounders were used to analyze the association between the lifestyle scores and SAD progression, as well as the MDiet and PA as separate variables and number of territories with plaque. Results: A healthier lifestyle score did not show an effect on SAD progression. However, a higher MEDAS score was associated with a 3% decrease in the number of territories with plaque (IRR 0.97, 95% CI 0.96-0.99, p < 0.001), suggesting a protective effect of the adherence to the MDiet. PA did not show a significant association (IRR 1.00, 95% CI 1.00-1.00, p = 0.269). Older age, hypertension, dyslipidemia, smoking, and lower eGFR were associated with SAD progression, while the female sex was protective (IRR 0.67, 95% CI 0.63-0.72, p < 0.001). Conclusions: The findings of this study show that higher adherence to the MDiet is associated with reduced incidence of SAD, indicating its potential role in cardiovascular prevention strategies. Although a higher lifestyle score or physical activity levels did not show any significant effect, promoting the MDiet, alongside managing traditional cardiovascular risk factors, could be an effective public health intervention to prevent atherosclerosis and reduce the burden of cardiovascular disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of Dietary Niacin on Metabolic Dysfunction-Associated Steatotic Liver Disease in Mediterranean Subjects, A Population-Based Study

  • Antentas Peraile, María|||0009-0005-8140-203X
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Vendrell Tito, Pau|||0009-0003-2020-5126
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Genua, Idoia|||0000-0001-6834-561X
  • Fernández-Camins, Berta|||0000-0001-7535-6181
  • Rossell, Joana|||0000-0003-1500-6379
  • Niño-Narvión, Julia|||0000-0001-6514-0731
  • Moreira, Estefanía
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Ortega, Emilio|||0000-0002-2217-8905
  • Vlacho, Bogdan|||0000-0003-3768-8112
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Mauricio, Didac|||0000-0002-2868-0250
  • Julve i Gil, Josep|||0000-0002-6531-2246
Background: The impact of dietary niacin on metabolic dysfunction-associated steatotic liver disease (MASLD) is elusive. This sub-study aimed to investigate the relationship between dietary niacin intake and the presence of MASLD in participants from two Catalonian cohorts. Methods: A total of 222 subjects with MASLD were age- and sex-matched to 222 non-MASLD subjects. Dietary nutrients were analyzed using a validated food frequency questionnaire (FFQ). Dietary niacin and other nutrients were adjusted for total energy intake. MASLD was defined by a Fatty Liver Index (FLI) of.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study

  • Puig, Rocío
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Ponomarenko, Julia|||0000-0002-1477-9444
  • Amézqueta, Susana
  • Vendrell, Joan|||0000-0002-6994-6115
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Torres, Josep Lluís|||0000-0002-5072-8265
  • Mauricio, Didac|||0000-0002-2868-0250
  • Ramos-Romero, Sara|||0000-0002-9293-4454
Background/Objectives: Gut microbiota is profoundly influenced by dysglycemic states, including prediabetes (preDM) and type 2 diabetes (T2D). Although short-chain fatty acids (SCFAs) may serve as proxies reflecting these microbial changes, their predictive role remains elusive. This study aimed to evaluate the association between fecal SCFA concentrations and glycemic status (preDM and T2D), using individuals with normoglycemia (NonDM) as the reference group in a Mediterranean adult population. Methods: This study included a total of 88 participants from the Di@bet.es study who were classified into three groups according to the American Diabetes Association criteria: NonDM (45%), preDM (27%), and T2D (28%), respectively. We evaluated gut microbiota populations through massive sequencing and determined SCFAs concentration using gas chromatography-mass spectrometry. Adjusted multiple logistic regression models were used to estimate associations between SCFAs and metabolic status. Results: The mean age of subjects with preDM and T2D was approximately 68 years, older than that of NonDM participants (about 60 years). About 50% of the subjects in the NonDM and preDM groups were female, whereas in the T2D group, females represented about 25%. The analysis revealed that only fecal acetic acid was significantly reduced in T2D compared to NonDM (p = 0.036) and preDM (p = 0.018) groups. Remarkably, fecal acetic acid was negatively associated with T2D risk when taking preDM as the reference state (OR = 0.561 [95% CI: 0.371-0.846], p = 0.009). Intriguingly, fecal acetic acid was identified as a significant positive predictor of preDM risk, taking the NonDM group as reference (OR = 1.422; p = 0.028), while propionic acid was inversely associated with preDM (OR = 0.714; p = 0.028). Conclusions: Our analysis showed that fecal acetic acid levels were associated with a reduced risk of T2D but also with an increased risk of preDM; however, the biological relevance of these findings remains uncertain.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between dietary niacin intake and diabetic retinopathy in a Catalonian population, a cross-sectional study

  • Torres-Méndez, Jeimy Katherine|||0000-0001-6299-8222
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Antentas Peraile, María|||0009-0005-8140-203X
  • Vendrell Tito, Pau|||0009-0003-2020-5126
  • Ortega, Emilio|||0000-0002-2217-8905
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Muscarà, Andrea
  • Rubinat, Esther|||0000-0003-0232-9777
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Hernández García, Marta|||0000-0003-1237-298X
  • Rossell, Joana|||0000-0003-1500-6379
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Mauricio, Didac|||0000-0002-2868-0250
  • Julve i Gil, Josep|||0000-0002-6531-2246
Background: Accumulating evidence suggests that niacin interventions may have a beneficial role in preventing ophthalmological microangiopathic remodeling. This study aimed to assess the impact of niacin intake on the presence of diabetic retinopathy (DR) in two independent Mediterranean cohorts of individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods: Cross-sectional, population-based epidemiologic study. A total of 243 individuals with T1D, and 291 individuals with T2D. All participants underwent an eye examination. Dietary niacin intake was analyzed using a validated Spanish 101-items food frequency questionnaire consumption. The association between niacin intake and DR was assessed using a multivariate logistic regression, with potential non-linear associations further explored through restricted cubic spline regression. DR diagnostic was established via multifield stereoscopic retinal photography, in accordance with the international consensus on DR. Results: DR was identified in 103 out of 243 individuals with T1D and 144 out of 291 with T2D. Dietary niacin intake did not differ within the study groups according to DR status. Multivariate logistic regression models also revealed no association between dietary niacin intake and DR. As previously described, the duration of diabetes for T1D and T2D, [OR (95%CI), 1.02 (1.01-1.03), and 1.02 (1.02-1.03), respectively] and glycated hemoglobin (HbA1c) [OR (95%CI), 1.16 (1.09-1.24), and 1.14 (1.09-1.18), respectively] were identified as the main determinant variables for DR in both groups. Conclusions: We found that dietary niacin intake was not associated with the presence of RD in subjects with either T1D or T2D. Further research is needed to better understand the potential role of niacin in the development or prevention of DR.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Association between dietary niacin intake and diabetic retinopathy in a Catalonian population: a cross-sectional study

  • Torres Méndez, Jeimy Katherine
  • Rojo López, Marina Idalia
  • Antentas, Maria
  • Vendrell, Pau
  • Ortega, Emilio
  • Alonso, Nuria
  • Castelblanco Echavarría, Esmeralda
  • Muscarà, Andrea
  • Rubinat, Esther
  • Alcubierre Calvo, Núria
  • Hernández García, Marta
  • Rossell, Joana
  • Granado Casas, Minerva
  • Mauricio Puente, Dídac
  • Julve, Josep
Background: Accumulating evidence suggests that niacin interventions may have a beneficial role in preventing ophthalmological microangiopathic remodeling. This study aimed to assess the impact of niacin intake on the presence of diabetic retinopathy (DR) in two independent Mediterranean cohorts of individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods: Cross-sectional, population-based epidemiologic study. A total of 243 individuals with T1D, and 291 individuals with T2D. All participants underwent an eye examination. Dietary niacin intake was analyzed using a validated Spanish 101-items food frequency questionnaire consumption. The association between niacin intake and DR was assessed using a multivariate logistic regression, with potential non-linear associations further explored through restricted cubic spline regression. DR diagnostic was established via multifield stereoscopic retinal photography, in accordance with the international consensus on DR. Results: DR was identified in 103 out of 243 individuals with T1D and 144 out of 291 with T2D. Dietary niacin intake did not differ within the study groups according to DR status. Multivariate logistic regression models also revealed no association between dietary niacin intake and DR. As previously described, the duration of diabetes for T1D and T2D, [OR (95%CI), 1.02 (1.01–1.03), and 1.02 (1.02–1.03), respectively] and glycated hemoglobin (HbA1c) [OR (95%CI), 1.16 (1.09–1.24), and 1.14 (1.09–1.18), respectively] were identified as the main determinant variables for DR in both groups. Conclusions: We found that dietary niacin intake was not associated with the presence of RD in subjects with either T1D or T2D. Further research is needed to better understand the potential role of niacin in the development or prevention of DR., The author(s) declare that financial support was received for the research and/or publication of this article. This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI21/00770 and PI24/00156 (to JJ), PI15/0625, PI18/0328, and PI12/0183 (to DM), FEDER “Una manera de hacer Europa”. JJ received financial support from Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033 and European Union “NextGeneration EU”;/PRTR) within the action “Consolidación Investigadora 2022” (CNS2022-135559). MR-L holds a predoctoral grant SLT017/20/000107 from Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021-2024 of Generalitat de Catalunya. Additionally, this study received support from Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM) (PI: Didac Mauricio, CB15/00071) and CIBER of Obesity and Nutrition (CIBEROBN) (PI: Emilio Ortega, CB06/03/0017), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain. Research Group, Endocrinology, Diabetes and Nutrition, Agencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR) (2021 SGR 01211), Institut de Recerca Sant Pau and Biomedical Research Institute's Dr. Pifarré Foundation from Lleida (IRBLleida) are accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA). The group also belongs to the XARTEC Salut network and is part of the coordinated consolidated group AGAUR (2021 SGR 00857, and 2021 SGR 01211). MR-L, DM, JR, and JJ are members of the Quality Research Group 2017-SGR-1149 from Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

  • Rodríguez-Agudo, Rubén
  • González-Recio, Irene
  • Serrano-Maciá, Marina
  • Bravo, Miren
  • Petrov, Petar D.
  • Blaya, Delia
  • Herranz, José María
  • Mercado-Gómez, María
  • Rejano-Gordillo, Claudia María
  • Lachiondo-Ortega, Sofía
  • Gil-Pitarch, Clàudia
  • Azkargorta, Mikel
  • Liempd, Sebastiaan Martijn van
  • Martínez-Cruz, Luis Alfonso
  • Simão, A. L.
  • Elortza, Félix
  • Martín, César
  • Nevzorova, Yulia A.
  • Cubero, Francisco Javier
  • Delgado, Teresa C.
  • Argemi, Josepmaria
  • Bataller, Ramón
  • Schoonjans, Kristina
  • Banales, Jesús M.
  • Castro, Rui E.
  • Sancho-Bru, Pau
  • Ávila, Matías A.
  • Julve, Josep
  • Jover, Ramiro
  • Mabe, Jon
  • Simón, Jorge
  • Goikoetxea-Usandizaga, Naroa
  • Martínez-Chantar, María Luz
© 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)., [Background & Aims] Current therapies for the treatment of alcohol-related liver disease (ALD) have proven largely ineffective. Patients relapse and the disease progresses even after liver transplantation. Altered epigenetic mechanisms are characteristic of alcohol metabolism given excessive acetate and NAD depletion and play an important role in liver injury. In this regard, novel therapeutic approaches based on epigenetic modulators are increasingly proposed. MicroRNAs, epigenetic modulators acting at the post-transcriptional level, appear to be promising new targets for the treatment of ALD., [Methods] MiR-873-5p levels were measured in 23 liver tissue from Patients with ALD, and GNMT levels during ALD were confirmed using expression databases (transcriptome n = 62, proteome n = 68). High-resolution proteomics and metabolomics in mice following the Gao-binge model were used to investigate miR-873-5p expression in ALD. Hepatocytes exposed to 50 mM alcohol for 12 h were used to study toxicity. The effect of anti-miR-873-5p in the treatment outcomes of ALD was investigated., [Results] The analysis of human and preclinical ALD samples revealed increased expression of miR-873-5p in the liver. Interestingly, there was an inverse correlation with NNMT, suggesting a novel mechanism for NAD depletion and aberrant acetylation during ALD progression. High-resolution proteomics and metabolomics identified miR-873-5p as a key regulator of NAD metabolism and SIRT1 deacetylase activity. Anti-miR-873-5p reduced NNMT activity, fuelled the NAD salvage pathway, restored the acetylome, and modulated the levels of NF-κB and FXR, two known SIRT1 substrates, thereby protecting the liver from apoptotic and inflammatory processes, and improving bile acid homeostasis., [Conclusions] These data indicate that targeting miR-873-5p, a repressor of GNMT previously associated with NAFLD and acetaminophen-induced liver failure. is a novel and attractive approach to treating alcohol-induced hepatoxicity., [Impact and implications] The role of miR-873-5p has not been explicitly examined in the progression of ALD, a pathology with no therapeutic options. In this study, inhibiting miR-873-5p exerted hepatoprotective effects against ALD through rescued SIRT1 activity and consequently restored bile acid homeostasis and attenuated the inflammatory response. Targeting hepatic miR-873-5p may represent a novel therapeutic approach for the treatment of ALD., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001136-S)., This work was supported by grants from Ministerio de Ciência, Innovación y Universidades MICINN: PID2020-117116RB-I00 CEX2021-001136-S integrado en el Plan Estatal de Investigación Científica y Técnica e Innovación, cofinanciado con Fondos FEDER (to MLM-C); Ministerio de Ciência e Innovación, Programa Retos-Colaboración RTC2019-007125-1 (to MLM-C); Instituto de Salud Carlos III, Proyectos Investigación en Salud DTS20/00138 (to MLM-C); La Caixa Scientific Foundation (HR17-00601) (for REC, MLM-C and JMB); La Caixa Consortium (to JMB, REC, KS and MLM-C); Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias co-founded by the European Union, PI20/00690, PI20/00765, PI20/01663 and PI21/00922 (to RJ, PS-B, JA and JMB respectively); Miguel Servet Programme CPII19/00008 (to JMB); AMMF-The Cholangiocarcinoma Charity (EU/2019/AMMFt/001) (to JMB); PSC Partners US and PSC Supports UK 06119JB (to JMB); European Union’s Horizon 2020 Research and Innovation Program, 825510 (for JMB) Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain) grant PI21/00770 (for JJ), Fundação para a Ciência e a Tecnologia (grants PTDC/MED-PAT/31882/2017 and EXPL/MED-OUT/1317/2021 to REC and ALS)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Association between dietary niacin intake and diabetic retinopathy in a Catalonian population: a cross-sectional study

  • Torres Méndez, Jeimy Katherine
  • Rojo López, Marina Idalia
  • Antentas, Maria
  • Vendrell, Pau
  • Ortega, Emilio
  • Alonso, Nuria
  • Castelblanco Echavarría, Esmeralda
  • Muscarà, Andrea
  • Rubinat, Esther
  • Alcubierre Calvo, Núria
  • Hernández García, Marta
  • Rossell, Joana
  • Granado Casas, Minerva
  • Mauricio Puente, Dídac
  • Julve, Josep
Background: Accumulating evidence suggests that niacin interventions may have a beneficial role in preventing ophthalmological microangiopathic remodeling. This study aimed to assess the impact of niacin intake on the presence of diabetic retinopathy (DR) in two independent Mediterranean cohorts of individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods: Cross-sectional, population-based epidemiologic study. A total of 243 individuals with T1D, and 291 individuals with T2D. All participants underwent an eye examination. Dietary niacin intake was analyzed using a validated Spanish 101-items food frequency questionnaire consumption. The association between niacin intake and DR was assessed using a multivariate logistic regression, with potential non-linear associations further explored through restricted cubic spline regression. DR diagnostic was established via multifield stereoscopic retinal photography, in accordance with the international consensus on DR. Results: DR was identified in 103 out of 243 individuals with T1D and 144 out of 291 with T2D. Dietary niacin intake did not differ within the study groups according to DR status. Multivariate logistic regression models also revealed no association between dietary niacin intake and DR. As previously described, the duration of diabetes for T1D and T2D, [OR (95%CI), 1.02 (1.01–1.03), and 1.02 (1.02–1.03), respectively] and glycated hemoglobin (HbA1c) [OR (95%CI), 1.16 (1.09–1.24), and 1.14 (1.09–1.18), respectively] were identified as the main determinant variables for DR in both groups. Conclusions: We found that dietary niacin intake was not associated with the presence of RD in subjects with either T1D or T2D. Further research is needed to better understand the potential role of niacin in the development or prevention of DR., The author(s) declare that financial support was received for the research and/or publication of this article. This work was funded by Spanish Ministry of Health, Instituto de Salud Carlos III (Madrid, Spain) grants PI21/00770 and PI24/00156 (to JJ), PI15/0625, PI18/0328, and PI12/0183 (to DM), FEDER “Una manera de hacer Europa”. JJ received financial support from Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033 and European Union “NextGeneration EU”;/PRTR) within the action “Consolidación Investigadora 2022” (CNS2022-135559). MR-L holds a predoctoral grant SLT017/20/000107 from Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021-2024 of Generalitat de Catalunya. Additionally, this study received support from Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM) (PI: Didac Mauricio, CB15/00071) and CIBER of Obesity and Nutrition (CIBEROBN) (PI: Emilio Ortega, CB06/03/0017), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain. Research Group, Endocrinology, Diabetes and Nutrition, Agencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR) (2021 SGR 01211), Institut de Recerca Sant Pau and Biomedical Research Institute's Dr. Pifarré Foundation from Lleida (IRBLleida) are accredited by the Generalitat de Catalunya as Centre de Recerca de Catalunya (CERCA). The group also belongs to the XARTEC Salut network and is part of the coordinated consolidated group AGAUR (2021 SGR 00857, and 2021 SGR 01211). MR-L, DM, JR, and JJ are members of the Quality Research Group 2017-SGR-1149 from Generalitat de Catalunya.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms

  • Torres-Méndez, Jeimy Katherine|||0000-0001-6299-8222
  • Niño-Narvión, Julia|||0000-0001-6514-0731
  • Martinez-Santos, Patricia
  • Diarte-Añazco, E. M. G.|||0000-0003-3876-9918
  • Méndez Lara, Karen Alejandra|||0000-0002-8372-2310
  • Vázquez del Olmo, Tania
  • Rotllan, Noemi|||0000-0002-0587-8045
  • Julián, María Teresa|||0000-0003-2524-1823
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Mauricio, Didac|||0000-0002-2868-0250
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Muñoz, Juan Pablo|||0000-0003-0912-4168
  • Rossell, Joana|||0000-0003-1500-6379
  • Julve i Gil, Josep|||0000-0002-6531-2246
This study investigated the effect of nicotinamide (NAM) supplementation on the development of brain inflammation and microglial activation in a mouse model of type 1 diabetes mellitus. C57BL/6J male mice, which were made diabetic with five consecutive, low-dose (55 mg/kg i.p.) streptozotocin (STZ) injections. Diabetic mice were randomly distributed in different experimental groups and challenged to different doses of NAM (untreated, NAM low-dose, LD, 0.1%; NAM high-dose, HD, 0.25%) for 25 days. A control, non-diabetic group of mice was used as a reference. The NAD+ content was increased in the brains of NAM-treated mice compared with untreated diabetic mice (NAM LD: 3-fold; NAM HD: 3-fold, p-value < 0.05). Immunohistochemical staining revealed that markers of inflammation (TNFα: NAM LD: -35%; NAM HD: -46%; p-value < 0.05) and microglial activation (IBA-1: NAM LD: -29%; NAM HD: -50%; p-value < 0.05; BDKRB1: NAM LD: -36%; NAM HD: -37%; p-value < 0.05) in brains from NAM-treated diabetic mice were significantly decreased compared with non-treated T1D mice. This finding was accompanied by a concomitant alleviation of nuclear NFκB (p65) signaling in treated diabetic mice (NFκB (p65): NAM LD: -38%; NAM HD: -53%, p-value < 0.05). Notably, the acetylated form of the nuclear NFκB (p65) was significantly decreased in the brains of NAM-treated, diabetic mice (NAM LD: -48%; NAM HD: -63%, p-value < 0.05) and inversely correlated with NAD+ content (r = -0.50, p-value = 0.03), suggesting increased activity of NAD+-dependent deacetylases in the brains of treated mice. Thus, dietary NAM supplementation in diabetic T1D mice prevented brain inflammation via NAD+-dependent deacetylation mechanisms, suggesting an increased action of sirtuin signaling.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

NAD+ Precursors and Intestinal Inflammation, Therapeutic Insights Involving Gut Microbiota

  • Niño-Narvión, Julia|||0000-0001-6514-0731
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Martinez-Santos, Patricia
  • Rossell, Joana|||0000-0003-1500-6379
  • Ruiz-Alcaraz, Antonio J.|||0000-0001-6913-0610
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Ramos-Molina, Bruno|||0000-0001-6804-5449
  • Mauricio, Didac|||0000-0002-2868-0250
  • Julve i Gil, Josep|||0000-0002-6531-2246
The oxidized form of nicotinamide adenine dinucleotide (NAD+) is a critical metabolite for living cells. NAD+ may act either as a cofactor for many cellular reactions as well as a coenzyme for different NAD+-consuming enzymes involved in the physiological homeostasis of different organs and systems. In mammals, NAD+ is synthesized from either tryptophan or other vitamin B3 intermediates that act as NAD+ precursors. Recent research suggests that NAD+ precursors play a crucial role in maintaining the integrity of the gut barrier. Indeed, its deficiency has been associated with enhanced gut inflammation and leakage, and dysbiosis. Conversely, NAD+-increasing therapies may confer protection against intestinal inflammation in experimental conditions and human patients, with accumulating evidence indicating that such favorable effects could be, at least in part, mediated by concomitant changes in the composition of intestinal microbiota. However, the mechanisms by which NAD+-based treatments affect the microbiota are still poorly understood. In this context, we have focused specifically on the impact of NAD+ deficiency on intestinal inflammation and dysbiosis in animal and human models. We have further explored the relationship between NAD+ and improved host intestinal metabolism and immunity and the composition of microbiota in vivo. Overall, this comprehensive review aims to provide a new perspective on the effect of NAD+-increasing strategies on host intestinal physiology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation, A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14

  • Sanjurjo, Lucía|||0000-0003-4006-8010
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Villalmanzo, Núria
  • Téllez, Érica|||0000-0003-1034-6307
  • Ramírez-Morros, Anna|||0000-0001-8263-1292
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Mauricio, Didac|||0000-0002-2868-0250
  • Sarrias, Maria-Rosa|||0000-0001-6929-8069
Atherosclerosis, a process in which macrophages play a key role, is accelerated in diabetes. Elevated concentrations of serum-oxidized low-density lipoproteins (oxLDL) represent a common feature of both conditions. The main goal of this study was to determine the contribution of oxLDL to the inflammatory response of macrophages exposed to diabetic-mimicking conditions. THP1 cells and peripheral blood monocytes purified from non-diabetic healthy donors were cultured under normal (5 mM) or high glucose (HG) (15 mM) with oxLDL. Then, foam cell formation, expression of CD80, HLADR, CD23, CD206, and CD163, as well as toll-like receptor 4 (TLR4) and co-receptors CD36 and CD14 (both at the cell surface and soluble (sCD14)), and inflammatory mediators' production were measured by flow cytometry, RT-qPCR, or ELISA. Additionally, serum sCD14 was determined in subjects with subclinical atherosclerosis with and without diabetes by ELISA. Our results showed that oxLDL-mediated intracellular lipid accumulation via CD36 increased under HG and that HG + oxLDL enhanced TNF, IL1B, and IL8, and decreased IL10. Moreover, TLR4 was upregulated in macrophages under HG and monocytes of subjects with diabetes and atherosclerosis. Interestingly, HG-oxLDL upregulated CD14 gene expression, although its total cellular protein abundance remained unaltered. sCD14 shedding via PRAS40/Akt-dependent mechanisms, with pro-inflammatory activity, was significantly increased in cultured macrophages and plasma from subjects with diabetes and subclinical atherosclerosis or hypercholesterolemia. Our data support an enhanced synergistic pro-inflammatory effect induced by HG and oxLDL in cultured human macrophages, possibly explained by increased sCD14 shedding.